Chemed Corp

465.37+3.79+0.82%Vol 63.95K1Y Perf -1.72%
Apr 9th, 2021 16:00 DELAYED
BID0.0000 ASK568.64
Open464.05 Previous Close461.58
Pre-Market- After-Market465.37
 - -  - -%
Target Price
592.50 
Analyst Rating
Strong Buy 1.25
Potential %
27.32 
Finscreener Ranking
★★★     50.71
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
★★+     50.47
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
★★★★+     68.64
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
★★+     43.83
Market Cap7.46B 
Earnings Rating
Buy
Price Range Ratio 52W %
39.39 
Earnings Date
27th Apr 2021

Today's Price Range

458.80465.99

52W Range

403.86560.00

5 Year PE Ratio Range

19.7057.70

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Sell
Performance
1 Week
-0.19%
1 Month
7.49%
3 Months
-15.03%
6 Months
-2.77%
1 Year
-1.72%
3 Years
66.00%
5 Years
244.04%
10 Years
622.73%

TickerPriceChg.Chg.%
CHE465.373.79000.82
AAPL132.992.63002.02
GOOG2 285.8820.44000.90
MSFT255.852.60001.03
XOM55.87-0.1300-0.23
WFC40.500.47001.17
JNJ161.25-1.7200-1.06
FB312.46-0.5600-0.18
GE13.600.15001.12
JPM156.281.16000.75
Financial StrengthValueIndustryS&P 500US Markets
1.00
1.10
0.10
0.15
169.10
Leverage Ratio 1.70
ProfitabilityValueIndustryS&P 500US Markets
33.70
19.20
21.90
14.50
17.08
RevenueValueIndustryS&P 500US Markets
1.56B
97.54
7.13
6.28
DividendsValueIndustryS&P 500US Markets
0.29
1.36
6.92
7.47
Payout ratio7.00
Earnings HistoryEstimateReportedSurprise %
Q04 20205.145.13-0.19
Q03 20203.994.8621.80
Q02 20203.794.4116.36
Q01 20203.603.682.22
Q04 20194.134.222.18
Q03 20193.313.464.53
Q02 20193.093.368.74
Q01 20192.982.92-2.01
Earnings Per EndEstimateRevision %Trend
3/2021 QR4.200.48Positive
6/2021 QR4.33-6.28Negative
12/2021 FY17.33-4.31Negative
12/2022 FY18.95--
Next Report Date27th Apr 2021
Estimated EPS Next Report4.20
Estimates Count2
EPS Growth Next 5 Years %7.00
Volume Overview
Volume63.95K
Shares Outstanding16.03M
Trades Count2.41K
Dollar Volume57.02M
Avg. Volume99.11K
Avg. Weekly Volume68.05K
Avg. Monthly Volume83.78K
Avg. Quarterly Volume99.84K

Chemed Corp (NYSE: CHE) stock closed at 465.37 per share at the end of the most recent trading day (a 0.82% change compared to the prior day closing price) with a volume of 63.95K shares and market capitalization of 7.46B. Is a component of Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Healthcare Providers & Services industry, Healthcare sector and employs 15544 people. Chemed Corp CEO is Kevin J. Mcnamara.

The one-year performance of Chemed Corp stock is -1.72%, while year-to-date (YTD) performance is -12.62%. CHE stock has a five-year performance of 244.04%. Its 52-week range is between 403.86 and 560, which gives CHE stock a 52-week price range ratio of 39.39%

Chemed Corp currently has a PE ratio of 23.60, a price-to-book (PB) ratio of 8.18, a price-to-sale (PS) ratio of 4.79, a price to cashflow ratio of 15.40, a PEG ratio of 2.32, a ROA of 22.69%, a ROC of 29.51% and a ROE of 37.76%. The company’s profit margin is 17.08%, its EBITDA margin is 21.90%, and its revenue ttm is $1.56 Billion , which makes it $97.54 revenue per share.

Of the last four earnings reports from Chemed Corp, there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $4.20 for the next earnings report. Chemed Corp’s next earnings report date is 27th Apr 2021.

The consensus rating of Wall Street analysts for Chemed Corp is Strong Buy (1.25), with a target price of $592.5, which is +27.32% compared to the current price. The earnings rating for Chemed Corp stock is Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Chemed Corp has a dividend yield of 0.29% with a dividend per share of $1.36 and a payout ratio of 7.00%.

Chemed Corp has a Neutral technical analysis rating based on Technical Indicators (ADX : 19.49, ATR14 : 16.44, CCI20 : -78.09, Chaikin Money Flow : -0.36, MACD : -23.09, Money Flow Index : 37.51, ROC : -9.49, RSI : 26.15, STOCH (14,3) : 17.36, STOCH RSI : 1.00, UO : 25.62, Williams %R : -82.64), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Chemed Corp in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
3 (75.00 %)
3 (75.00 %)
3 (75.00 %)
Moderate Buy
1 (25.00 %)
1 (25.00 %)
1 (25.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.25
Strong Buy
1.25
Strong Buy
1.25

Chemed Corp

Chemed Corp operates subsidiaries in two main segments: VITAS and Roto-Rooter. The VITAS segment generates the majority of the firm's revenue. It provides hospice and palliative-care services to patients with terminal illnesses through a network of physicians, registered nurses, home health aides, social workers, and volunteers. The vast majority of the segment's revenue is received from the Medicare and Medicaid reimbursement programs. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration, and related services to residential and commercial customers. It also manufactures products and equipment used to provide these services. Chemed generates the majority of its revenue from business in the United States.

CEO: Kevin J. Mcnamara

Telephone: +1 513 762-6690

Address: 255 East Fifth Street, Cincinnati 45202-4726, OH, US

Number of employees: 15 544

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

53%47%

Bearish Bullish

58%42%

Bearish Bullish

54%46%

News

Stocktwits